What is it about?

In this report López-Noriega et al. demonstrate that levothyroxine (T4) enhances glucose clearance in healthy mice via enhanced pancreatic β-cell turnover and increased expression and secretion of insulin. T4 increases β-cell proliferation, favoring the maintenance of insulin expression and secretion in the RIP-B7.1 model of experimental autoimmnune diabetes and increasing survival in a model of streptozotocin-induced diabetes.

Featured Image

Read the Original

This page is a summary of: Levothyroxine enhances glucose clearance and blunts the onset of experimental type 1 diabetes mellitus in mice, Bone Marrow Transplantation, September 2017, Wiley,
DOI: 10.1111/bph.13975.
You can read the full text:

Read

Contributors

Be the first to contribute to this page